Innovations in Contraception: A Review
review
OA: closed
CC0
AI-generated summary
This review discusses innovations in contraception, including low-dose hormones, new progestins, compliance strategies, transdermal patches, vaginal rings, intrauterine systems, and hysteroscopic sterilization.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
New forms of contraception have been developed to improve the safety and tolerability of contraceptive methods without compromising efficacy. The newest developments in contraception including low and ultra-low doses of estrogen, less-androgenic 19 nor-testosterone progestins, and the nonsteroidal progestin drospirenone, the Quick Start method to improve compliance of oral contraceptives, and the contraceptive transdermal patch, the vaginal estrogen-progestin ring, the levonorgestrel intrauterine system, and the hysteroscopic transcervical sterilization techniques are discussed.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (36)
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
- doi:10.1111/j.1471-0528.2000.tb11610.x via openalex
- doi:10.1016/0010-7824(87)90012-6 via openalex
- doi:10.1016/j.jmig.2005.05.016 via openalex
- doi:10.1016/s0020-7292(00)85161-9 via openalex
- doi:10.1016/0010-7824(95)00074-k via openalex
- doi:10.1016/j.jemermed.2005.01.009 via openalex
- doi:10.1016/j.fertnstert.2003.12.032 via openalex
- doi:10.1016/s1074-3804(04)80344-x via openalex
- W101561822 via openalex
- doi:10.1016/s0010-7824(02)00514-0 via openalex
- doi:10.1136/bmj.318.7176.96 via openalex
- doi:10.2307/2135494 via openalex
- doi:10.1097/00006250-200111000-00016 via openalex
- doi:10.1016/s0010-7824(02)00351-7 via openalex
- doi:10.1016/s0140-6736(05)63015-2 via openalex
- W2193389020 via openalex
- doi:10.1016/s0015-0282(16)59881-1 via openalex
- W6661480132 via openalex
- W6687516920 via openalex
- W6759186675 via openalex
- doi:10.1016/s0010-7824(96)00189-8 via openalex
- doi:10.1093/humrep/deh604 via openalex
- doi:10.1016/j.jpag.2006.05.014 via openalex
- doi:10.3949/ccjm.70.8.681 via openalex
- doi:10.1016/j.contraception.2005.11.003 via openalex
- doi:10.1016/s0002-9378(96)70658-0 via openalex
- doi:10.1016/s0010-7824(03)00141-0 via openalex
- doi:10.1007/978-1-4615-0689-8_20 via openalex
- doi:10.1016/s0029-7844(01)01534-4 via openalex
- doi:10.1016/s1083-3188(02)00214-0 via openalex
- doi:10.1111/j.1479-828x.2001.tb01311.x via openalex
- doi:10.1001/jama.285.18.2347 via openalex
- doi:10.4065/81.10.1290 via openalex
- doi:10.1093/humrep/deg256 via openalex
- doi:10.1016/s0010-7824(00)00083-4 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:07:48.142452+00:00
License: CC0
· commercial use OK